Vericel Corporation (VCEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VCEL | AMGN | BMY | GILD | VRTX |
| Company | Vericel Corporation | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 45.49 | 273.45 | 47.39 | 67.47 | 402.44 |
| High | 45.63 | 274.35 | 47.50 | 67.90 | 403.88 |
| Low | 44.50 | 267.24 | 44.67 | 65.32 | 393.00 |
| Last | 45.26 | 268.81 | 44.72 | 65.55 | 398.77 |
| Change | -0.85 | -4.20 | -4.14 | -1.53 | -1.99 |
| % Change | -1.84% | -1.54% | -8.47% | -2.28% | -0.50% |
| Volume | 52,814 | 597,844 | 23,500,278 | 4,385,988 | 319,799 |
| 20-Day Average Volume | 342,672 | 2,088,112 | 11,736,444 | 6,314,005 | 939,187 |
| Previous Close | 46.11 | 273.01 | 48.86 | 67.08 | 400.76 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 48.43 | 270.64 | 49.96 | 68.70 | 402.24 |
| 20-Day Raw Stochastic | 27.59% | 26.34% | 4.33% | 2.22% | 17.26% |
| 20-Day Relative Strength | 45.28% | 43.66% | 29.17% | 28.87% | 41.75% |
| Weighted Alpha | +44.00 | +8.36 | -33.92 | -23.34 | +14.29 |
| Today's Opinion | 56% Buy | 72% Sell | 88% Sell | 100% Sell | 8% Buy |
| Previous Opinion | 56% Buy | 40% Sell | 88% Sell | 100% Sell | 8% Buy |
| Last Month's Opinion | 100% Buy | 24% Buy | 8% Sell | 88% Sell | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.33% since 04/18/24 | +2.01% since 04/18/24 | -6.64% since 04/18/24 | -0.98% since 04/18/24 | +0.71% since 04/18/24 |
| Low | 42.38 on 04/19/24 | 260.68 on 04/19/24 | 44.67 on 04/25/24 | 65.32 on 04/25/24 | 391.25 on 04/19/24 |
| High | 47.14 on 04/23/24 | 274.86 on 04/24/24 | 49.56 on 04/22/24 | 67.78 on 04/25/24 | 406.86 on 04/23/24 |
| 1-Month | |||||
| %Chg | -5.47% since 03/25/24 | -4.56% since 03/25/24 | -13.69% since 03/25/24 | -9.74% since 03/25/24 | -4.75% since 03/25/24 |
| Low | 42.38 on 04/19/24 | 260.68 on 04/19/24 | 44.67 on 04/25/24 | 65.32 on 04/25/24 | 391.01 on 04/18/24 |
| High | 53.05 on 04/01/24 | 288.57 on 03/28/24 | 54.47 on 03/28/24 | 73.87 on 03/28/24 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | +6.38% since 01/25/24 | -13.61% since 01/25/24 | -9.10% since 01/25/24 | -18.35% since 01/25/24 | -7.84% since 01/25/24 |
| Low | 41.58 on 02/07/24 | 260.68 on 04/19/24 | 44.67 on 04/25/24 | 65.32 on 04/25/24 | 391.01 on 04/18/24 |
| High | 53.05 on 04/01/24 | 329.72 on 02/05/24 | 55.03 on 03/13/24 | 80.51 on 01/26/24 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | +31.97% since 10/25/23 | -1.52% since 10/25/23 | -20.34% since 10/25/23 | -16.43% since 10/25/23 | +9.15% since 10/25/23 |
| Low | 32.28 on 11/09/23 | 249.70 on 10/31/23 | 44.67 on 04/25/24 | 65.32 on 04/25/24 | 341.90 on 11/16/23 |
| High | 53.05 on 04/01/24 | 329.72 on 02/05/24 | 55.29 on 10/26/23 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,230,802 | 146,436,016 | 99,027,448 | 83,519,768 | 103,580,040 |
| Shares Outstanding, K | 48,380 | 536,376 | 2,026,759 | 1,245,077 | 258,459 |
| Annual Sales | 197,520,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -3,180,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 65,000,000 | 8,196,000,000 | 11,477,000,000 | 7,114,000,000 | 2,517,700,000 |
| Last Quarter Net Income | 12,990,000 | 767,000,000 | 1,762,000,000 | 1,429,000,000 | 968,800,000 |
| 60-Month Beta | 1.71 | 0.58 | 0.39 | 0.19 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.26 on 02/29/24 | 4.71 on 02/06/24 | 1.70 on 02/02/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 |
| Latest Earnings Date | 05/08/24 | 05/02/24 | 04/25/24 | 04/25/24 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.600 on 04/04/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 04/04/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.67 | 6.53 | 9.97 | 30.13 |